What is Global Natural Killer Cell Therapy Market?
The Global Natural Killer Cell Therapy Market is a rapidly growing sector in the field of medical science. It refers to the use of natural killer (NK) cells, a type of white blood cell, in the treatment of various diseases. These cells play a crucial role in the body's immune response, particularly in the fight against cancer. The market encompasses the development, production, and distribution of therapies that utilize these cells. The global market for NK cell therapy has seen significant growth in recent years, driven by advancements in medical technology and an increased understanding of the role of NK cells in disease treatment. The market includes various types of therapies, such as autologous and allogeneic NK cell therapies, and covers a wide range of diseases, including cancer and gastrointestinal diseases.
NK Cell Therapies, NK Cell Directed Antibodies in the Global Natural Killer Cell Therapy Market:
NK Cell Therapies and NK Cell Directed Antibodies are two key components of the Global Natural Killer Cell Therapy Market. NK Cell Therapies involve the use of NK cells, either from the patient (autologous) or from a donor (allogeneic), to treat diseases. These therapies have shown promise in the treatment of various types of cancer, including leukemia and lymphoma. On the other hand, NK Cell Directed Antibodies are drugs that target NK cells, enhancing their ability to fight disease. These antibodies can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. The development and use of these therapies are driven by ongoing research and clinical trials, which aim to improve their effectiveness and reduce side effects.
Cancer, Gastrointestinal Diseases, Others in the Global Natural Killer Cell Therapy Market:
The Global Natural Killer Cell Therapy Market has a wide range of applications, particularly in the treatment of cancer and gastrointestinal diseases. In cancer treatment, NK cell therapies are used to enhance the body's immune response to cancer cells. They can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. In the treatment of gastrointestinal diseases, NK cell therapies can help to reduce inflammation and promote healing. Other applications of NK cell therapies include the treatment of autoimmune diseases and viral infections. The versatility of these therapies, combined with ongoing research and development, is driving their increased use in various areas of medicine.
Global Natural Killer Cell Therapy Market Outlook:
The Global Natural Killer Cell Therapy Market has shown significant growth in recent years. In 2023, the market was valued at US$ 255.8 million. However, it is expected to reach a staggering US$ 1185.5 million by 2030, reflecting a compound annual growth rate (CAGR) of 24.2% during the forecast period from 2024 to 2030. The Americas, in particular, have been leading the way in the market, accounting for 52.3% of the global market share in 2019. The cancer segment has been a major contributor to this growth, accounting for 66.99% of the market share in 2019. Furthermore, the top six players in the market accounted for 96.66% of the global revenue market share in 2019, demonstrating the competitive nature of this market.
| Report Metric | Details |
| Report Name | Natural Killer Cell Therapy Market |
| Accounted market size in 2023 | US$ 255.8 million |
| Forecasted market size in 2030 | US$ 1185.5 million |
| CAGR | 24.2% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
